ALIA THERAPEUTICS
Alia Therapeutics is developing next-generation gene-editing medicines to cure rare genetic diseases.
ALIA THERAPEUTICS
Industry:
Biotechnology Therapeutics
Founded:
2018-01-01
Address:
Trento, Trentino-Alto Adige, Italy
Country:
Italy
Website Url:
http://www.aliatherapeutics.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
1.46 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon WordPress Wordpress Plugins Mobile Non Scaleable Content Nginx
Similar Organizations
30 Technology
30 TECHNOLOGY is developing and defining new models of care by unlocking the potential of Nitric Oxide.
AAVantgarde Bio
AAVantgarde Bio is developing gene therapies for inherited retinal disorders.
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Alcyone Therapeutics
Alcyone Therapeutics is Pioneering Next-Generation Precision CNS Genetic Therapies to unlock new possibilities
Algentech
Algentech specialises in the development of cutting edge technologies for gene editing and synthetic biology tools applications.
Auregen BioTherapeutics
Auregen BioTherapeutics provides 3D bioprinting technology for innovative treatments to cure rare disorders.
Autobahn Therapeutics
Autobahn Therapeutics is a developer of regenerative medicines to restore hope for people affected by CNS disorders.
Avrion Therapeutics
Avrion Therapeutics is a precision Gene Therapies for Neurodegenerative Diseases.
Borea Therapeutics
Borea Therapeutics is advancing a new generation of gene therapies that would enable the targeting of specific tissues and cells.
CHARM Therapeutics
CHARM Therapeutics uses deep learning on 3D molecular configurations to develop molecule therapeutics to target pathogenic proteins.
CoA Therapeutics
CoA Therapeutics develops novel therapies for difficult to treat and rare genetic disorders.
CORAT Therapeutics
CORAT Therapeutics develops an innovative therapeutic drug composed of a novel fully human neutralizing antibody against COVID-19.
Diotheris
Diotheris develops bacterial therapies of the human skin and mucosal microbiome intended to protect against pathogenic bacteria.
Empyrean Therapeutics
Empyrean Therapeutics develops next generation cell therapies to enable global and affordable cures for diseases.
Epsilen Bio
Epsilen Bio is developing a transformative therapy known as Epigenetic Silencing to treat human diseases.
Femtogenix
Femtogenix is develop next generation DNA-interactive payload molecules for use in antibody-drug conjugates.
FF Gene Biotech
FF Gene Biotech was founded to bring Fulgent Genetics’ Next Generation Sequencing (NGS) capabilities to the Chinese genetic testing market.
Keapstone Therapeutics
Keapstone Therapeutics is the next generation of drugs targeting a key pathway in neurodegeneration.
MimiX Biotherapeutics
mimiX Biotherapeutics provides a point-of-care tissue engineering approach to regenerative, patient-tailored precision medicine.
Modis Therapeutics
Modis Therapeutics is bringing disease-modifying therapies to patients with rare genetic diseases.
NOGA Therapeutics
NOGA Therapeutics is a Developing Gene Therapies to Cure Primary Immune Deficiencies.
OcuTerra Therapeutics
OcuTerra Therapeutics is developing novel eye drop designed to treat diabetic eye disease.
OxVax
OxVax focused on the development of an advanced next-generation dendritic cell vaccine platform for the treatment of solid tumor cancers.
Quantum Genomics
Quantum Genomics is developing therapies for unmet medical needs in the field of cardiovascular diseases
Saverna Therapeutics
Saverna Therapeutics use the latest artificial intelligence tools to discover small molecules targeting RNA
Slingshot Biosciences
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
Solstice Pharmaceuticals
Solstice Pharmaceuticals dedicated to creating the next generation of diagnostic and therapeutic ultrasound products.
VacciZone
Vaccizone is developing antigen delivery and vaccine technologies for human and animal diseases based on its novel ASC technology.
Current Advisors List
Current Employees Featured
Founder
Investors List
Sofinnova Partners
Sofinnova Partners investment in Seed Round - Alia Therapeutics
Trentino Invest Srl
Trentino Invest Srl investment in Seed Round - Alia Therapeutics
BiovelocITA
BiovelocITA investment in Seed Round - Alia Therapeutics
Official Site Inspections
http://www.aliatherapeutics.com
- Host name: carnage.evtel.com
- IP address: 18.156.43.197
- Location: Frankfurt am Main Germany
- Latitude: 50.1188
- Longitude: 8.6843
- Timezone: Europe/Berlin
- Postal: 60313
